1-5 of 5
STeven Kornblau, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

Steven Kornblau, M.D., M. D. Minden, MD, PhD, David B. Rosen, PhD, Santosh Putta, PhD, Aileen C. Cohen, MD, PhD, Todd Covey, Wendy J. Fantl, PhD, Urte Gayko, PhD, Alessandra Cesano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1582.
https://doi.org/10.1182/blood.V114.22.1582.1582
Published: 2009
Journal Articles

Imatinib Frontline Therapy Is Safe and Effective in Patients with Chronic Myeloid Leukemia (CML) with Liver and/or Renal Dysfunction.

Weigang Tong, M.D., Ph.D., Hagop Kantarjian, M.D., Susan O’Brien, M.D., Stefan Faderl, MD, Farhad Ravandi, MBBS, William G Wierda, M.D., Ph.D., Steven Kornblau, M.D., Gautam Borthakur, M.D., Guillermo Garcia-Manero, M.D., Elizabeth Burton, Mary Beth Rios, Jorge Cortes, M.D.
Journal: Blood
Blood (2008) 112 (11): 2126.
https://doi.org/10.1182/blood.V112.11.2126.2126
Published: 2008
Journal Articles

Adaptation of Augmented Berlin-Frankfurt-Munster (ABFM) Therapy in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL).

Michael Rytting, MD, Deborah Thomas, M.D., Hagop Kantarjian, M.D., Jorge Cortes, M.D., Gautam Borthakur, M.D., William Wierda, M.D., Cesar Nunez, M.D., Steven Kornblau, M.D., Farhad Ravandi, M.D., Robert Wells, M.D., Muriera Brenda, R.N., Franklin Anna, M.D., Susan O’Brien, M.D.
Journal: Blood
Blood (2007) 110 (11): 4342.
https://doi.org/10.1182/blood.V110.11.4342.4342
Published: 2007
Journal Articles

Phase II Study of CEP701, an Orally Available JAK2 Inhibitor, in Patients with Primary Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.

Srdan Verstovsek, MD, PhD, Ayalew Tefferi, M.D., Steven Kornblau, M.D., Deborah Thomas, M.D., Jorge Cortes, M.D., Farhad Ravandi-Kashani, M.D., Guillermo Garcia-Manero, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2007) 110 (11): 3543.
https://doi.org/10.1182/blood.V110.11.3543.3543
Published: 2007
Journal Articles

A Phase II Study of Azacitidine (Vidaza™) for Patients with Myelofibrosis (MF).

Alfonso Quintas-Cardama, MD, Hagop Kantarjian, M.D., Guillermo Garcia-Manero, M.D., Deborah Thomas, M.D., STeven Kornblau, M.D., Elihu Estey, M.D., Marilyn Nemri, R.N., Jorge Cortes, M.D., Francis Giles, M.D., Srdan Verstovsek, M.D.;PhD
Journal: Blood
Blood (2006) 108 (11): 2706.
https://doi.org/10.1182/blood.V108.11.2706.2706
Published: 2006